Your browser doesn't support javascript.
COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
Buchbinder, Susan P; McElrath, M Juliana; Dieffenbach, Carl; Corey, Lawrence.
  • Buchbinder SP; Bridge HIV, San Francisco Department of Public Health, San Francisco, CA 94102, USA; Department of Medicine and Department of Epidemiology, University of California, San Francisco, CA, USA. Electronic address: susan.buchbinder@sfdph.org.
  • McElrath MJ; Fred Hutchinson Cancer Research Institute, Seattle, WA, USA; University of Washington, Seattle, WA, USA.
  • Dieffenbach C; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Corey L; Fred Hutchinson Cancer Research Institute, Seattle, WA, USA; University of Washington, Seattle, WA, USA.
Lancet ; 399(10333): e36, 2022 04 09.
Article in English | MEDLINE | ID: covidwho-1778511
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV-1 / HIV Seropositivity / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV-1 / HIV Seropositivity / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2022 Document Type: Article